Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
14,482 total articles
I’m reversing a prior sell call and recommending a mid-term long on Microsoft. Despite heavy AI-driven capex across Big Tech, Microsoft’s operating metrics and cash generation remain strong — free cash flow of $72.9B, ROE ~30%, and an EV/EBITDA of ~16.5 — leaving room for revenue upside from Azure and AI services and scope for multiple re-rating. T…
Accenture (ACN) is trading at an attractive valuation after a prolonged pullback. The business still generates strong free cash flow ($12.5B), has low leverage (debt/equity 0.16) and a 3.6% yield. At roughly $180 and a P/E near 14x, we see a high-probability swing trade to $259.79 within a 45 trading-day horizon, with a $168 stop to protect capital…
Rigetti is trading as a narrative stock today, but recent government funding, sector-wide re-rating and improving technicals give this run a plausible runway. The fundamentals remain speculative - negative EPS, negative free cash flow and sky-high valuation - but a disciplined mid-term swing trade can capture upside if bookings and cloud revenue mo…
Micron's AI-driven HBM adoption and strong cash generation justify an upgrade to a tactical long. Valuation is rich, but fundamentals and momentum support a mid-term trade into the June earnings window. Entry $1005.00, stop $930.00, target $1250.00, horizon: mid term (45 trading days).
Visa's headline legal risk has roiled sentiment, but the company’s capital-light network, $21.2B in free cash flow, and 51% return on equity argue for buying strength. This note lays out a tactical long trade with entry, stop, targets and the key risks that would invalidate the setup.
Alphabet's $85 billion stock sale is larger than most corporate liquidity events and will materially increase tradable supply, alter ETF/prime broker flows and shift buyback math. That creates a short-term dislocation and a mid-to-long-term opportunity to buy quality cash flow at a modest multiple if management deploys proceeds rationally. Trade pl…
FTAI Aviation ($251.58) is trading like an aviation services name but now carries optionality from FTAI Power's engine-to-turbine conversions and AI-driven operations with Palantir. The stock is richly valued, but upcoming data-center demand and recent strategic deals offer a clear mid-term trade setup.
Publicis (PUBGY) looks like a classic opportunity to buy on fear: the business is cash-generative, pays a healthy yield, and is doubling down on AI through a strategic Microsoft relationship. Valuation is reasonable (P/E ~13.3, market cap ~$26.1B) and technical momentum is bullish. I upgrade to a buy and lay out an actionable trade with entry, stop…
Accenture is uniquely positioned to monetize enterprise AI deployment at scale. The stock trades cheaply on several cash-flow metrics while partnerships and federal work create visible revenue levers. This trade idea targets a recovery toward fair value over the next 180 trading days with a tight stop and clear catalysts.
Heritage Insurance (HRTG) remains in a corrective phase technically, but fundamentals and valuation argue for staged buying. The company trades at a P/E near 3.1, generates strong free cash flow, and reported a sharp profit rebound in Q2 2025. I lay out a mid-term (45 trading days) trade plan with entry, stop and target and a balanced risk framewor…
Zevia (ZVIA) looks set for a tactical rebound. The stock trades near $1.42 after carving a base above its February low; balance-sheet liquidity, reasonable valuation (EV/Sales ~0.42), and concentrated short interest create a setup where earnings and margin stabilization could trigger a rapid move higher. This is a medium-risk swing trade sized for …
Marvell is benefitting from a structural move away from copper networking toward optics inside hyperscale data centers. Strong data-center revenue, a high-growth product slate (Teralynx switch, DCI optics), and renewed momentum after a public endorsement create an actionable trade setup. We outline entry, stop and target levels for a long position …
Duke Energy is courting technology companies to manage the execution risk on its large capital projects tied to AI and data-center driven electrification. The company trades at about $121.54, yields ~3.5%, and carries a market cap near $94.8B. This trade idea recommends a long position with entry at $121.54, a target of $134.00 and a stop at $115.0…
TG Therapeutics' positive Phase 1 subcutaneous BRIUMVI results represent a clear de-risking event for the company’s flagship MS franchise. With accelerating sales, raised guidance, a reasonable P/E of ~13x, and significant short interest, the stock offers an asymmetric opportunity. We outline an actionable long trade with entry, target, and stop, a…
SpaceX's imminent IPO and a credible path to a 2027 Tesla-SpaceX combination materially raise the expected upside for Tesla equity. Tesla's $1.59T market cap, strong cash position and AI/semiconductor roadmap make it a plausible acquirer or merger partner. We upgrade the stance and lay out an actionable long trade with precise entry, stop and targe…
Rocket Lab’s stock at roughly $118 is pricing an almost impossibly successful Neutron rollout into valuation. With a market cap near $68B, negative free cash flow, and an EV/sales north of 96x, the risk-reward favors sellers until Neutron demonstrates reliable, repeatable economics. This trade targets a pullback over the next 45 trading days with a…
Aurinia (AUPH) is trading near 52-week highs but still offers a reasonable valuation: market cap roughly $2.1B, trailing EPS about $2.32 and free cash flow of $166.6M. The business generates cash today while late-stage lupus/lupus nephritis market dynamics and guideline shifts create meaningful catalysts over the next 3-6 months. Trade plan: long A…
Danone is trading near the low end of its 52-week range despite tangible progress on strategic moves: confirmed 2026 guidance, the Huel acquisition, a dairy JV in Argentina, and strengthened funding for precision fermentation partners. The stock looks like a dairy multiple but the company is increasingly a platform play in functional nutrition. We …
Atour Lifestyle is building scale across hotels and retail experiences while returning cash to shareholders. With a $4.85B market cap, mid-30s valuation, and accelerating revenue growth, ATAT is a candidate for a long trade into a catalyst window (dividend, buybacks, travel recovery). The trade below balances upside to the 52-week highs with a defi…
We upgrade Mondelez to a buy for a swing trade. The company offers steady free cash flow, a 3.2% yield, and improving revenue momentum as cocoa prices ease — all while the shares sit below their 52-week high and technicals show room to run. Entry at $62.43, stop at $58.50 and targets at $67.00 and $71.15 for a mid-term (45 trading days) hold.
Alkami (ALKT) looks primed for a re-rating after a large institutional purchase, strong recent revenue growth and talk of a shareholder vote around a buyback. The balance of improving fundamentals and continued execution risk makes this a medium-risk, long-term trade: entry $16.70, stop $14.10, target $24.00 over roughly 180 trading days.
Atour Lifestyle (ATAT) has the ingredients for another leg higher: rapid room rollouts, double-digit revenue growth, a shareholder-friendly capital allocation push and an upcoming dividend distribution. Technicals are mixed today, but a disciplined entry around the $35 area with a tight stop and a target near the 52-week highs gives a favorable ris…
Grifols is trading cheaply (market cap $6.42B, P/E ~10.6, P/B ~0.81) while the underlying plasma-derived therapies market is growing strongly. Near-term headline risk out of Canada has hit the stock, but resolution or containment of that regulatory episode, combined with improved plasma self-sufficiency trends and continued demand for immunoglobuli…
NBT Bancorp (NBTB) trades at a modest P/E of ~12.7 and a P/B near 1.22, pays a 3.2% yield, and has scale ($16.11B assets) following the Evans Bancorp merger. This trade targets $52 with a $40 stop, keyed to stable fundamentals, improving footprint in Upstate New York, and attractive cash flow metrics.
Microchip Technology is showing early signs of margin stabilization while its data center business is scaling quickly. With the Data Center Solutions unit posting $302.7M in 2025 and management projecting roughly $500M in 2026 (a 65% increase), the stock can re-rate if margins and free cash flow continue improving. This is a tactical swing trade: e…
